The slip
PARKINSON RECEIPTno. 4789
21 Oct 2026, 01:49 UTCdopamine neurons, braak
predictionSLC35F5 in dopamine neurons tracks Braak Lewy-body stage
registeredd579c8db926bf121
discovery+0.77 p=0.015 n=9
replication+0.00 p=1.000 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery +0.77 p 0.015; held-out +0.00 p 1.000)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATEacdafa7edca273c20df46b6d…
follows 6a150ebb5107…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4789: SLC35F5 in dopamine neurons, braak
- power
- full sample +0.42 (p 0.082, n 18), 95% CI -0.06 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.47 (p 0.050, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.64 (p 0.0044, n 18). not the mix.
- skeptic
- leave-one-out range +0.35 to +0.59, sign flips 0; without severely affected donors +0.42 (p 0.082, n 18). robust.
- cell type
- strongest in microglia: -0.62 (p 0.0060, n 18) vs +0.42 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC35F5 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SLC35F5 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.75 p 0.0077 (needs p < 4.1e-4)